Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) SHH

11.63

+0.29(+2.56%)

Updated at August 19 11:30AM

Currency In CNY

Valuation

Market Cap8.26B
Enterprise Value7.44B
P/E Ratio46.9
PEG Ratio-2.34
Price/Sales Ratio12.16
Price/Book Ratio4.22
Enterprise/Revenue11.15
Enterprise/EBITDA28.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.27
Operating Margin0.32

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue795.29M
Revenue/Share0.94
Gross Profit431.31M
EBITDA311.62M
Net Income206.79M
Diluted EPS0.25

Balance Sheet

Total Cash1.11B
Total Cash/Share1.3
Total Debt291.11M
Total Debt/Equity0.12
Current Ratio2.57
Book Value Per Share2.79

Price History

52-Week Change60
52-Week High12.32
52-Week Low6.52
Moving Average 50 Days9.7
Moving Average 200 Days8.85

Statistics

Average Volume24.09M
Shares Outstanding830.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.85
Payout Ratio0.39
Last Split Factor7:5
Last Split DateJuly 12, 2024